123 related articles for article (PubMed ID: 2410170)
1. Inhibition of natural killing and antibody-dependent cell-mediated cytotoxicity by the plasma protease inhibitor alpha 2-macroglobulin (alpha 2M) and alpha 2M protease complexes.
Dickinson AM; Shenton BK; Alomran AH; Donnelly PK; Proctor SJ
Clin Immunol Immunopathol; 1985 Sep; 36(3):259-65. PubMed ID: 2410170
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the immune response by plasma protease inhibitors. II. Alpha 2-macroglobulin subunits inhibit natural killer cell cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
Gravagna P; Gianazza E; Arnaud P; Neels M; Ades EW
Scand J Immunol; 1982 Jan; 15(1):115-8. PubMed ID: 6176015
[TBL] [Abstract][Full Text] [Related]
3. Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors.
Gonias SL; Balber AE; Hubbard WJ; Pizzo SV
Biochem J; 1983 Jan; 209(1):99-105. PubMed ID: 6189480
[TBL] [Abstract][Full Text] [Related]
4. Conformation and protease binding activity of binary and ternary human alpha 2-macroglobulin-protease complexes.
Gonias SL; Pizzo SV
J Biol Chem; 1983 Dec; 258(23):14682-5. PubMed ID: 6196365
[TBL] [Abstract][Full Text] [Related]
5. The methylamine reactive site and protease inhibition in alpha 2-macroglobulin.
Howard JB; Swenson R; Eccleston E
Ann N Y Acad Sci; 1983; 421():160-6. PubMed ID: 6202192
[TBL] [Abstract][Full Text] [Related]
6. Reaction of human alpha 2-macroglobulin half-molecules with plasmin as a probe of protease binding site structure.
Gonias SL; Pizzo SV
Biochemistry; 1983 Oct; 22(21):4933-40. PubMed ID: 6196052
[TBL] [Abstract][Full Text] [Related]
7. Protease binding by alpha 2 macroglobulin in cystic fibrosis.
Bridges MA; Applegarth DA; Johannson J; Wong LT; Davidson AG
Clin Chim Acta; 1982 Jan; 118(1):33-43. PubMed ID: 6172220
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of electrophoretically "slow" and "fast" form alpha 2-macroglobulin. Effects on cell-mediated cytotoxicity and (allo-) antigen-induced T cell proliferation.
Petersen CM; Ejlersen E; Moestrup SK; Jensen PH; Sand O; Sottrup-Jensen L
J Immunol; 1989 Jan; 142(2):629-35. PubMed ID: 2463311
[TBL] [Abstract][Full Text] [Related]
9. Relation of internal thioesters to conformational change and receptor-recognition site in alpha 2-macroglobulin complexes.
Van Leuven F; Marynen P; Cassiman JJ; Van den Berghe H
Biochem J; 1982 May; 203(2):405-11. PubMed ID: 6180729
[TBL] [Abstract][Full Text] [Related]
10. Identification of a monoclonal antibody specific for a neoantigenic determinant on alpha 2-macroglobulin: use for the purification and characterization of binary proteinase-inhibitor complexes.
Strickland DK; Steiner JP; Migliorini M; Battey FD
Biochemistry; 1988 Mar; 27(5):1458-66. PubMed ID: 2452653
[TBL] [Abstract][Full Text] [Related]
11. Effect of protease binding by alpha 2-macroglobulin on intrinsic fluorescence.
Straight DL; McKee PA
Biochemistry; 1982 Sep; 21(19):4550-6. PubMed ID: 6182901
[TBL] [Abstract][Full Text] [Related]
12. Three high molecular weight protease inhibitors of rat plasma. Reactions with trypsin.
Lonberg-Holm K; Reed DL; Roberts RC; Damato-McCabe D
J Biol Chem; 1987 Apr; 262(10):4844-53. PubMed ID: 2435719
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-macroglobulin-mediated clearance of proteases from the plasma of the American horseshoe crab, Limulus polyphemus.
Melchior R; Quigley JP; Armstrong PB
J Biol Chem; 1995 Jun; 270(22):13496-502. PubMed ID: 7539428
[TBL] [Abstract][Full Text] [Related]
14. Mapping of structure-function relationships in proteins with a panel of monoclonal antibodies. A study on human alpha 2 macroglobulin.
Van Leuven F; Marynen P; Cassiman JJ; Van den Berghe H
J Immunol Methods; 1988 Jun; 111(1):39-49. PubMed ID: 2455752
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of horse alpha 2-macroglobulin protease inhibitor.
Pellegrini A; Zweifel HR; von Fellenberg R
Int J Biochem; 1983; 15(8):1003-11. PubMed ID: 6194020
[TBL] [Abstract][Full Text] [Related]
16. Study on proteinase-inhibiting capacity of plasma alpha 2-macroglobulin in idiopathic nephrotic syndrome.
Asami T; Nishihara T; Tomisawa S; Sakai K; Uchiyama M
Nephron; 1996; 72(4):512-7. PubMed ID: 8730413
[TBL] [Abstract][Full Text] [Related]
17. Degradation of a chromogenic substrate by alpha 2-macroglobulin from plasma of patients with rheumatoid arthritis.
Teodorescu M; Gaspar A; Spear G; Skosey JL; Ganea D
Arthritis Rheum; 1984 Oct; 27(10):1122-9. PubMed ID: 6207846
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the plasma protease inhibitor alpha 2-macroglobulin by the antitumor drug cis-dichlorodiamineplatinum(II).
Gonias SL; Pizzo SV
J Biol Chem; 1981 Dec; 256(23):12478-84. PubMed ID: 6170643
[TBL] [Abstract][Full Text] [Related]
19. Design of a new protease inhibitor by the manipulation of the bait region of alpha 2-macroglobulin: inhibition of the tobacco etch virus protease by mutant alpha 2-macroglobulin.
Van Rompaey L; Proost P; Van den Berghe H; Marynen P
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):191-5. PubMed ID: 7492312
[TBL] [Abstract][Full Text] [Related]
20. Anomalous alpha 2-macroglobulin-protease complexes in cystic fibrosis: decreased uptake of the complexes by fibroblasts in culture.
Van Leuven F; Cassiman JJ; Van Den Berghe H
Pediatr Res; 1979 Dec; 13(12):1384-6. PubMed ID: 93265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
